United States: § 112(a) Is A Priority In Decision To Institute IPR; Did Not Work To Say Petitioner Should Have Filed A PGR - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Credit: Mondaq- Published on August 24, 2023
Petitioner Dr. Reddy's Laboratories challenged the patentability of several claims of U.S. Patent No. 11,110,087 ("the '087 patent") on 35 U.S.C. § 102 anticipation grounds. IPR2023-00052, Paper 7 at *4.

You are here


Related videos from verified sources

US Opposes New Plan to Investigate Titanic Wreckage 01:31
Credit: Wibbitz Top Stories - Published on August 31, 2023 


The CCP As The Fifth Column with Col. Lawrence Sellin
Credit: Rumble - Published on August 31, 2023 


USA issues advisory for its citiizens as Haiti's internecine gang wars continue unabated | Oneindia 03:03
Credit: Oneindia - Published on August 31, 2023 


Related news from verified sources

In this podcast, Kevin Rodkey and Derrick Brent highlight the remarkable pro bono initiatives and resources offered by the United States Patent and Trademark...
on August 2, 2023 • Mondaq

On June 15, 2023, the USPTO issued a Final Rule on the Standardization of the Patent Term Adjustment Statement Regarding Information Disclosure Statements.
on August 1, 2023 • Mondaq

How does a stakeholder get notified of an eGrant? Issue Notifications will be available electronically via Patent Center after the payment of the issue fee....
on August 4, 2023 • Mondaq

You might like